Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.019 | 0.7 |